Benjamin Paluch

Stock Analyst at Roth MKM

(2.00)

# 2,879

Out of 4,711 analysts

3

Total ratings

66.67%

Success rate

1.05%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$28.67	+126.72%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$12.49	+36.11%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.27	+340.53%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $28.67

Upside: +126.72%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $12.49

Upside: +36.11%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.27

Upside: +340.53%